BML-265
BML-265 is a potent and selective EGFR tyrosine kinase inhibitor that induces Golgi apparatus disruption and impairs secretory protein transport in human cells, while showing no such effect in rodent cells. This species-specific mechanism makes it a valuable research tool for studying EGFR signaling, Golgi biology, and protein trafficking in vitro.
Product Specifications
CAS Number
183321-62-2
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
C#CC1=CC=CC (=C1) NC=2N=CN=C3C=C (OC) C (OC) =CC32
Molecular Formula
C18H15N3O2
Molecular Weight
305.331
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6351790-01 0.1 mL
STARD6, CT (STARD6, StAR-related lipid transfer protein 6, START domain-containing protein 6) (MaxLight 405)
Sign In for Pricing
View Details MBS6351790-02 5x 0.1 mL
STARD6, CT (STARD6, StAR-related lipid transfer protein 6, START domain-containing protein 6) (MaxLight 405)
Sign In for Pricing
View Details 
PA1478-Fluoro488 100 µg/Vial
Anti-Fos B/FOSB Antibody Picoband® Fluoro488 Conjugated
Sign In for Pricing
View Details 